Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.

MLA

Ponzo, Matteo, et al. “Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.” Cancers, vol. 14, no. 17, Aug. 2022. EBSCOhost, https://doi.org/10.3390/cancers14174265.

APA

Ponzo, M., Debesset, A., Cossutta, M., Chalabi-Dchar, M., Houppe, C., Pilon, C., Nicolas-Boluda, A., Meunier, S., Raineri, F., Thiolat, A., Nicolle, R., Maione, F., Brundu, S., Cojocaru, C. F., Bouvet, P., Bousquet, C., Gazeau, F., Tournigand, C., Courty, J., … Cascone, I. (2022). Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers, 14(17). https://doi.org/10.3390/cancers14174265

Chicago

Ponzo, Matteo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, et al. 2022. “Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.” Cancers 14 (17). doi:10.3390/cancers14174265.